Toomas Asser

1.3k total citations
49 papers, 984 citations indexed

About

Toomas Asser is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Toomas Asser has authored 49 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 11 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Toomas Asser's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Toomas Asser is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Toomas Asser collaborates with scholars based in Estonia, Germany and Norway. Toomas Asser's co-authors include Tõnu Rätsep, Pille Taba, Tambet Teesalu, Andres Kulla, Ave Minajeva, Prakash Lingasamy, Rolf Bjerkvig, Allan Tobi, Ülla Linnamägi and Sulev Haldre and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

In The Last Decade

Toomas Asser

47 papers receiving 968 citations

Peers

Countries citing papers authored by Toomas Asser

Since Specialization

Citations

This map shows the geographic impact of Toomas Asser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toomas Asser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toomas Asser more than expected).

Fields of papers citing papers by Toomas Asser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toomas Asser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toomas Asser. The network helps show where Toomas Asser may publish in the future.

Co-authorship network of co-authors of Toomas Asser

This figure shows the co-authorship network connecting the top 25 collaborators of Toomas Asser. A scholar is included among the top collaborators of Toomas Asser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toomas Asser. Toomas Asser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in traumatic spinal cord injuries in Estonia from 1997 to 2018 2022 ·Journal of Spinal Cord Medicine ·Liis Sabre, (unknown), (unknown), Toomas Asser, Janika Kõrv	1
2	Tumor-penetrating peptide for systemic targeting of Tenascin-C 2020 ·Scientific Reports ·Prakash Lingasamy, Allan Tobi, (unknown), Sergei Kopanchuk, (unknown), (unknown), Tõnu Rätsep, Toomas Asser, Rolf Bjerkvig, Tambet Teesalu	55
3	Aneurysmal subarachnoid haemorrhage: effect of CRHR1 genotype on fatigue and depression 2020 ·BMC Neurology ·Artur Vetkas, Ele Prans, Sulev Kõks, Tõnu Rätsep, Toomas Asser	4
4	The Effect of Functional Electrical Stimulation and Therapeutic Exercises on Trunk Muscle Tone and Dynamic Sitting Balance in Persons with Chronic Spinal Cord Injury: A Crossover Trial 2019 ·Medicina ·(unknown), (unknown), (unknown), Toomas Asser, Helena Gapeyeva, (unknown)	13
5	Peptide-guided nanoparticles for glioblastoma targeting 2019 ·Journal of Controlled Release ·Pille Säälik, Prakash Lingasamy, (unknown), (unknown), Liat Rousso-Noori, Allan Tobi, Lorena Simón‐Gracia, Hedi Hunt, Päärn Paiste, Venkata Ramana Kotamraju, Gabriele Bergers, Toomas Asser, Tõnu Rätsep, Erkki Ruoslahti, Rolf Bjerkvig, Dinorah Friedmann‐Morvinski, Tambet Teesalu	79
6	Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery 2019 ·Biomaterials ·Prakash Lingasamy, Allan Tobi, Maarja Haugas, Hedi Hunt, Päärn Paiste, Toomas Asser, Tõnu Rätsep, Venkata Ramana Kotamraju, Rolf Bjerkvig, Tambet Teesalu	56
7	Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls 2018 ·Ultrasound in Medicine & Biology ·Toomas Toomsoo, Inga Liepelt‐Scarfone, Daniela Berg, (unknown), Allan‐Hermann Pool, Liis Kadastik‐Eerme, (unknown), Toomas Asser, Pille Taba	11
8	Prevalence of depressive symptoms and their association with brainstem raphe echogenicity in patients with Parkinson's disease and non-PD controls 2017 ·Psychiatry Research Neuroimaging ·Toomas Toomsoo, (unknown), Inga Liepelt‐Scarfone, Liis Kadastik‐Eerme, Toomas Asser, (unknown), Daniela Berg, Pille Taba	9
9	The effect of subthalamic stimulation on viscoelastic stiffness of skeletal muscles in patients with Parkinson's disease 2017 ·Clinical Biomechanics ·Tõnu Rätsep, Toomas Asser	10
10	Substantia Nigra Hyperechogenicity 2015 ·Journal of Ultrasound in Medicine ·Toomas Toomsoo, Inga Liepelt‐Scarfone, (unknown), Liis Kadastik‐Eerme, Toomas Asser, (unknown), Daniela Berg, Pille Taba	10
11	Mortality and causes of death after traumatic spinal cord injury in Estonia 2013 ·Journal of Spinal Cord Medicine ·Liis Sabre, Tiina Rekand, Toomas Asser, Janika Kõrv	29
12	The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury 2009 ·Trials ·Haleema Shakur‐Still, Peter Andrews, Toomas Asser, Laura Balica, (unknown), (unknown), Yashbir Dewan, Patrick Druwé, Olivia Fletcher, Chris Frost, Bennie Hartzenberg, (unknown), F. Murillo‐Cabezas, Jan Pachl, (unknown), Indrek Rätsep, Cristina Sampaio, Manmohan Singh, Petr Svoboda, Ian Roberts	36
13	Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39) 2008 ·Health and Quality of Life Outcomes ·(unknown), Pille Taba, Taavi Lai, Toomas Asser	17
14	Possible interpretation of subjective complaints in patients with spontaneous subarachnoid haemorrhage 2004 ·Journal of Rehabilitation Medicine ·Aaro Toomela, Aleksander Pulver, Tiiu Tomberg, (unknown), (unknown), Toomas Asser	26
15	Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system 2004 ·Thrombosis and Haemostasis ·Andres Kulla, (unknown), Vappu Sirén, Daniel A. Lawrence, Toomas Asser, Antti Vaheri, Tambet Teesalu	67
16	Alterations in opioid system of the rat brain after cat odor exposure 2004 ·Neuroscience Letters ·(unknown), Sulev Kõks, Mari‐Anne Philips, Eero Vasar, Alar Karis, Toomas Asser	12
17	Incidence of Parkinson’s Disease in Estonia 2003 ·Neuroepidemiology ·Pille Taba, Toomas Asser	13
18	Prevalence of Parkinson's disease in Estonia 2002 ·Acta Neurologica Scandinavica ·Pille Taba, Toomas Asser	25
19	Routine Utilization of the Transient Hyperaemic Response Test after Aneurysmal Subarachnoid Haemorrhage 2002 ·PubMed ·Tõnu Rätsep, (unknown), Toomas Asser	4
20	Seizure Disorders in Patients with Brain Tumors 2001 ·European Neurology ·(unknown), Sulev Haldre, Andre Õun, Ülla Linnamägi, (unknown), Toomas Asser, (unknown)	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact